Post-approval studies (Phase 4)Ended earlyNCT01512472What this trial is testingFirmagon (Degarelix) Intermittent TherapyWho this might be right forProstate Cancer Recurrent Canadian Urology Research Consortium 144
Not applicableUnknownNCT01938339What this trial is testingDevelopment of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate CancerWho this might be right forProstate Cancer RecurrentStage II Prostate CarcinomaStage III Prostate Carcinoma Seoul National University Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT01786265What this trial is testingFinite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate CancerWho this might be right forProstate AdenocarcinomaRecurrent Prostate Carcinoma M.D. Anderson Cancer Center 310
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03753334What this trial is testingEffects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.Who this might be right forProstate Cancer CHU de Quebec-Universite Laval 39
Not applicableNot Yet RecruitingNCT07290998What this trial is testingAlpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate CancerWho this might be right forProstate CancerRecurrent Prostate CancerLocally Recurrent Prostate Cancer Alpha Tau Medical LTD. 12
Testing effectiveness (Phase 2)Study completedNCT01750398What this trial is testingBipolar Androgen-based Therapy for Prostate Cancer (BAT)Who this might be right forRecurrent Prostate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Not applicableEnded earlyNCT00288106What this trial is testingS0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPTWho this might be right forProstate Cancer SWOG Cancer Research Network 961
Not applicableEnded earlyNCT04234399What this trial is testingDetermination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomyWho this might be right forProstatic Neoplasm University of Vermont 22
Testing effectiveness (Phase 2)Study completedNCT01946165What this trial is testingAbiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and EnzalutamideWho this might be right forProstate Cancer M.D. Anderson Cancer Center 69
Early research (Phase 1)Active Not RecruitingNCT04457232What this trial is testingProspective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology ValidationWho this might be right forMetastatic Malignant Neoplasm in the Prostate GlandProstate CarcinomaRecurrent Prostate Carcinoma Jonsson Comprehensive Cancer Center 30
Not applicableLooking for participantsNCT05597852What this trial is testingUsing Rectal Hydrogel Spacer for Salvage SABR in Prostate CancerWho this might be right forProstate Cancer Sunnybrook Health Sciences Centre 10
Testing effectiveness (Phase 2)Ended earlyNCT02420652What this trial is testingMetformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation TherapyWho this might be right forRecurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more Rutgers, The State University of New Jersey 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557What this trial is testingPembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With EnzalutamideWho this might be right forCastration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more OHSU Knight Cancer Institute 58
Early research (Phase 1)Ended earlyNCT04267939What this trial is testingATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian CancerWho this might be right forAdvanced Solid Tumors (Excluding Prostate Cancer)Ovarian Cancer Bayer 14
Early research (Phase 1)Ended earlyNCT00313534What this trial is testingNordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate CancerWho this might be right forProstate Cancer University of California, San Francisco 15
Testing effectiveness (Phase 2)Study completedNCT01120236What this trial is testingBicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerWho this might be right forProstate AdenocarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer National Cancer Institute (NCI) 211
Very early researchLooking for participantsNCT06462495What this trial is testingHead-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and MetastasisWho this might be right forProstate CancerPET/CT Anhui Provincial Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01599793What this trial is testingMagnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate CancerWho this might be right forBone MetastasesCastrate-resistant Prostate CancerRecurrent Prostate Cancer+1 more University of Chicago 19
Large-scale testing (Phase 3)Study completedNCT02981368What this trial is testingStudy of 18F-DCFPyL PET/CT Imaging in Patients With Prostate CancerWho this might be right forProstate Cancer Progenics Pharmaceuticals, Inc. 385